We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study

News   Jan 27, 2012

 
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study
 
 
Advertisement
 

RELATED ARTICLES

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

A High-resolution 3D View Inside Tumors

News

Researchers have now succeeded in visualizing spatial changes within tumors using optoacoustics. This method could be helpful for the future development of new anticancer drugs.

READ MORE

First Confirmation of Microplastics in Florida's Birds of Prey

News

A new study has confirmed and quantified, for the first time, the presence of microplastics in terrestrial and aquatic birds of prey in Florida, including hawks, ospreys and owls.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE